Katherine (Kathy) Pappas focuses her practice on intellectual property matters, particularly in patent litigation within the life sciences sector. Kathy handles matters involving a large variety of technologies, ranging from mechanical inventions (e.g., microfluidic devices; injector pens) to pharmaceutical litigation under the Hatch-Waxman Act.
Prior to her legal career, Kathy worked in psychology and neuroscience research and treatment, from which she brings a unique skillset.
- Assisted trial team in obtaining a verdict finding an injector pen for insulin delivery did not infringe Sanofi’s patent, and further finding Sanofi’s patent invalid (Sanofi-Aventis v. Mylan (D.N.J.))*
*Matter handled prior to joining McDermott.
University of California Los Angeles School of Law, JD, 2019
Hampshire College, BA, Psychology with a minor in Cognitive Neuroscience, 2012
Courts / Agencies
US District Court for the Southern District of California